HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junjie Liu Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

1/2022Evaluation of Diagnostic and Prognostic Value of hsa_circ_0084927 and Analysis of Associated ceRNA Network in Colorectal Cancer.
1/2021Regulation of Long Non-coding RNA KCNQ1OT1 Network in Colorectal Cancer Immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junjie Liu Research Topics

Disease

69Neoplasms (Cancer)
11/2022 - 10/2012
11Hepatocellular Carcinoma (Hepatoma)
11/2022 - 11/2018
10Breast Neoplasms (Breast Cancer)
10/2021 - 10/2013
7Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2019
6Liver Neoplasms (Liver Cancer)
08/2019 - 01/2015
4Neoplasm Metastasis (Metastasis)
07/2022 - 12/2017
4Hypoxia (Hypoxemia)
02/2020 - 12/2017
3Reperfusion Injury
01/2022 - 01/2020
3Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2021
3Ischemic Stroke
01/2022 - 01/2019
3Melanoma (Melanoma, Malignant)
01/2022 - 12/2012
3Stroke (Strokes)
01/2022 - 01/2019
3Thrombosis (Thrombus)
01/2022 - 11/2018
3Infections
01/2020 - 01/2012
3Kidney Neoplasms (Kidney Cancer)
01/2016 - 10/2012
2Carcinogenesis
07/2022 - 08/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 01/2020
2Inflammation (Inflammations)
01/2022 - 01/2022
2Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2021
2Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2020
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2020
2Heart Failure
12/2020 - 01/2020
2Nasopharyngeal Carcinoma
09/2020 - 04/2014
2Insulin Resistance
01/2020 - 01/2020
2Wounds and Injuries (Trauma)
01/2020 - 05/2018
1Facial Paralysis (Facial Palsy)
08/2022
1Pathologic Processes
08/2022
1Paralysis (Palsy)
08/2022
1Bell Palsy (Bell's Palsy)
08/2022
1Adenocarcinoma
07/2022
1Triple Negative Breast Neoplasms
07/2022

Drug/Important Bio-Agent (IBA)

20Pharmaceutical PreparationsIBA
08/2022 - 11/2013
11Silicon Dioxide (Silica)FDA LinkGeneric
01/2020 - 10/2013
9MicroRNAs (MicroRNA)IBA
07/2022 - 08/2017
9Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 06/2015
8Long Noncoding RNAIBA
11/2022 - 01/2019
7Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
7Therapeutic UsesIBA
01/2021 - 04/2014
6Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2016
61-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2021 - 02/2018
6Peptides (Polypeptides)IBA
01/2020 - 01/2015
5AcidsIBA
07/2022 - 10/2015
5Photosensitizing Agents (Photosensitizers)IBA
07/2022 - 12/2019
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2020
5NADPH Oxidases (NAD(P)H oxidase)IBA
06/2021 - 06/2015
5Glutathione (Reduced Glutathione)IBA
01/2021 - 10/2014
5salinomycinIBA
01/2019 - 01/2015
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 11/2013
4Drug CarriersIBA
07/2022 - 05/2014
4DNA (Deoxyribonucleic Acid)IBA
12/2021 - 05/2018
4Docetaxel (Taxotere)FDA Link
01/2019 - 10/2013
3Cisplatin (Platino)FDA LinkGeneric
07/2022 - 07/2018
3Free RadicalsIBA
07/2022 - 01/2020
3Messenger RNA (mRNA)IBA
01/2022 - 06/2015
3CytokinesIBA
01/2022 - 01/2021
3Competitive Endogenous RNAIBA
01/2022 - 01/2021
3Oxygen (Dioxygen)IBA
01/2021 - 12/2017
3AntigensIBA
01/2020 - 10/2012
3Hyaluronic Acid (Hyaluronan)IBA
01/2016 - 10/2013
2CopperIBA
07/2022 - 02/2020
2Metal-Organic FrameworksIBA
07/2022 - 01/2022
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 07/2018
2Catalytic DNA (Deoxyribozyme)IBA
01/2022 - 12/2021
2Transferrin (beta 2 Transferrin)IBA
01/2022 - 01/2018
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2021 - 01/2020
2Insulin (Novolin)FDA Link
12/2021 - 01/2020
2Sirtuin 1IBA
07/2021 - 11/2018
2RNA (Ribonucleic Acid)IBA
01/2021 - 12/2019
2Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 01/2020
2CholesterolIBA
01/2021 - 01/2018
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
2Adenosine Triphosphate (ATP)IBA
11/2020 - 10/2020
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2020 - 10/2020
2Liposomes (Liposome)IBA
11/2019 - 01/2016
2poly(lactide) (polylactic acid)IBA
01/2019 - 01/2016
2Small Interfering RNA (siRNA)IBA
11/2018 - 03/2014
2Protein Isoforms (Isoforms)IBA
01/2018 - 06/2015
2Lipid Bilayers (Lipid Bilayer)IBA
11/2017 - 10/2013
2Polylactic Acid-Polyglycolic Acid CopolymerIBA
01/2016 - 01/2014
2EnzymesIBA
04/2015 - 02/2015
1Cell Adhesion MoleculesIBA
08/2022
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2022
1GlucocorticoidsIBA
08/2022
1Estrogens (Estrogen)FDA Link
07/2022
1ProdrugsIBA
07/2022
1Arginine (L-Arginine)FDA Link
07/2022
1protoporphyrin IXIBA
07/2022
1Cetuximab (Erbitux)FDA Link
01/2022
1Thymidine Monophosphate (TMP)IBA
01/2022

Therapy/Procedure

40Therapeutics
07/2022 - 10/2012
17Drug Therapy (Chemotherapy)
07/2022 - 10/2013
9Photochemotherapy (Photodynamic Therapy)
12/2021 - 11/2017
6Radiotherapy
09/2020 - 10/2013
3Immunotherapy
01/2022 - 01/2020
2Photothermal Therapy
01/2021 - 06/2017
2Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2020 - 08/2019
2Lasers (Laser)
01/2018 - 05/2014
2Precision Medicine
12/2017 - 06/2017
1Ligation
11/2022
1Radiofrequency Ablation
03/2022